Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Discover the importance of using asset allocation to balance risk and return. This strategy can enhance your investment performance.
28,655 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Si-Bone stock soared almost 20% on Tuesday as investors reacted to strong quarterly results and optimistic guidance. ...
A major fund just boosted its stake in a struggling auto-parts retailer. This article breaks down what the move could...
Mara Holdings faced a tough trading day as its stock slumped amid disappointing earnings and swinging crypto prices. ...
Money stories outlive bank balances. Learn to tell yours clearly, protect loved ones, and build a legacy that reflect...
A high-profile insider sale can shake investor nerves. This guide explains what the Dropbox stock sell after event mi...
NASA plans a March liftoff for Artemis II after resolving a dangerous hydrogen leak that halted February fueling test...
Biotech earnings chants are rarely about profits for small developers. This guide explains how to read Celcuity's 202...
Investors are eyeing a renewed push for a classic dividend king as a robust oncology portfolio and resilience in earn...
A high-profile Georgia case shows how Medicaid billing can go wrong and cost taxpayers. This guide breaks down what h...
Can political plans truly unlock cheaper loans and more homes? This guide breaks down what Trump’s housing proposals ...
Warren Buffett resurfaces on CNBC as Berkshire Hathaway shares retreat, highlighting leadership transition questions ...